0001213900-22-024978.txt : 20220510 0001213900-22-024978.hdr.sgml : 20220510 20220509200610 ACCESSION NUMBER: 0001213900-22-024978 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20220509 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220510 DATE AS OF CHANGE: 20220509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DocGo Inc. CENTRAL INDEX KEY: 0001822359 STANDARD INDUSTRIAL CLASSIFICATION: LOCAL & SUBURBAN TRANSIT & INTERURBAN HWY PASSENGER TRAINS [4100] IRS NUMBER: 852515483 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39618 FILM NUMBER: 22906875 BUSINESS ADDRESS: STREET 1: 35TH STREET WEST 35TH STREET 2: FLOOR 6 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: (844) 443-6246 MAIL ADDRESS: STREET 1: 35TH STREET WEST 35TH STREET 2: FLOOR 6 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: Motion Acquisition Corp. DATE OF NAME CHANGE: 20200824 8-K 1 ea159635-8k_docgo.htm CURRENT REPORT
0001822359 false 0001822359 2022-05-09 2022-05-09 0001822359 DCGO:CommonStockParValue0.0001PerShareMember 2022-05-09 2022-05-09 0001822359 DCGO:WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember 2022-05-09 2022-05-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 9, 2022

 

DOCGO INC. 

(Exact name of registrant as specified in its charter)

 

Delaware 001-39618 85-2515483
(State or other jurisdiction
of incorporation) 		(Commission
File Number)		 (IRS Employer
Identification No.)

 

35 West 35th Street, Floor 6, New York, New York
(Address of principal executive offices)		 10001
(Zip Code)

 

(844) 443-6246

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

  

Name of each exchange on

which registered

Common stock, par value $0.0001 per share   DCGO   The Nasdaq Stock Market LLC
Warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share   DCGOW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

  

Item 2.02 Results of Operations and Financial Condition

 

On May 9, 2022, DocGo Inc. (the “Company”) issued a press release that announced earnings results for the quarter ended March 31, 2022. This press release is furnished as Exhibit 99.1 to this report.

 

The information in Item 2.02 of this report and the exhibit attached hereto is being furnished and shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit No. Description
   
99.1 Press release of DocGo Inc. dated May 9, 2022
   
104 Cover Page Interactive Data File (formatted as Inline XBRL)

 

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  DOCGO INC.
     
  By: /s/ Andre Oberholzer
    Name: Andre Oberholzer
    Title:   Chief Financial Officer

 

Date: May 9, 2022

 

 

2

 EX-99.1 2 ea159635ex99-1_docgo.htm PRESS RELEASE OF DOCGO INC. DATED MAY 9, 2022

Exhibit 99.1

 

DocGo Announces Strong First Quarter 2022 Results

Q1 Revenue of $118 Million Up 137% Over Comparable Prior Year Period

Bolsters Senior Staff, Expands Market Footprint

NEW YORK, NY, May 9, 2022 - DocGo (Nasdaq:DCGO), a leading provider of last-mile mobile health services and integrated medical transportation solutions, today announced financial and operating results for the first quarter ending March 31, 2022.

“During the first quarter we were able to continue our momentum from 2021, as we began the transition of some Covid-related services to longer term non-Covid related work both with new and existing customers.  Our goal is to make this transition as seamless as possible. While there are challenges, we are making great progress,” stated Stan Vashovsky, Chief Executive Officer and Co-Founder of DocGo.  “We also continue to expand our breadth and geographic reach, adding new services in new states, while bolstering the strength of our operational team.  Not only did DocGo grow revenue 137% over the year-ago period, but we also generated strong net income and cash flow, and we expect to see continued improvements in profitability over time. We continue to operate in a vast, untapped market with a scalable and capital efficient business model. Our first quarter results represent a strong start to what I anticipate will be a successful 2022, and I look forward to sharing additional updates.”

 

First Quarter Financial Highlights

·Total revenue was $117.9 million. The Company estimates that Q1 2022 Covid testing revenues amounted to $38 million.
·Q1 2022 total revenue of $117.9 million represents an increase of 137% over $49.7 million in total revenue for the first quarter of 2021, which included $20.4 million of Covid testing revenues. Excluding Covid testing revenues from both periods, total revenues in Q1 2022 increased by approximately 173% from Q1 2021.
·The Company estimates that Covid testing revenue accounted for approximately 32% of total revenues in Q1 2022, compared to 41% in Q4 2021.
·Mobile Health revenue increased to approximately $90.1 million, compared to $30.6 million in the first quarter of 2021. The increase reflects the extension of certain key contracts as well as a number of new contracts.
·Medical transport revenue was approximately $27.8 million, up 46% from $19.1 million in the first quarter of 2021.
·Net income was $9.4 million, compared to a net loss of $2.0 million in the first quarter of 2021.
·Adjusted EBITDA(1) grew to approximately $13.6 million, versus Adjusted EBITDA of $0.4 million in the first quarter of 2021.

 

1

 

 

Select Corporate Highlights

 

·Expanded our presence in New York and New Jersey through a new, multi-year contract with Aetna for our DocGo On-Demand Mobile Urgent Care service. The service will be provided to Aetna’s commercial and Medicare Advantage members in New York and New Jersey.
·Strengthened our senior management ranks by hiring Lee Bienstock, a seasoned professional who spent the last 10 years at Google across various business units and initiatives, as DocGo’s Chief Operating Officer.
·Interacted with 1.1 million patients in Q1 2022, representing an 88% increase over the same period in 2021.
·Announced the launch of America’s first all-electric EV ambulance, and DocGo’s ‘Zero Emission’ initiative with the goal of converting our entire fleet of ambulances to EV by 2032. Subsequently, we completed our first patient transport in partnership with Jefferson Health.
·Awarded three new contracts in the UK, adding new service areas to East England and Central England, and further expanding our footprint in Greater Manchester.
·Expanded our relationship with Carnival Corporation, adding 15 additional ships and launching services in Mobile, Alabama.
·Acquired new medical transportation licenses in Delaware and Maryland, expanding our US transportation footprint to eleven states.
·Hosted a “Fireside Chat” format investor event featuring marquee customers Carnival Corporation and Thomas Jefferson University, who discussed why they chose DocGo for their companies’ mobile health and medical transportation needs.

2022 Guidance

The company continues to see strong demand from its customers for both mobile health and transportation services. Accordingly, the company is reiterating its prior revenue guidance for fiscal year 2022 of approximately $400-420 million. This represents growth of 25-32% over 2021 revenues. Excluding estimated Covid testing revenues from both years, its 2022 revenue guidance would represent an annual increase of 65% - 75% over 2021(3). Adjusted EBITDA(2) is anticipated to be approximately $35-41 million for 2022.

 

 

1 Adjusted EBITDA is a non-GAAP financial measure. See “Non-GAAP Financial Measures” below for additional information on this non-GAAP financial measure and a reconciliation to the most comparable GAAP measure.

2 Adjusted EBITDA is a non-GAAP financial measure. We have not reconciled Adjusted EBITDA outlook to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management’s control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measure (net income). Forward- looking estimates of Adjusted EBITDA are made in a manner consistent with the relevant definitions and assumptions noted herein.

3 See table below for additional detail.

******

2

 

Conference call and webcast

DocGo management will host a conference call and webcast to discuss the first quarter results tomorrow, May 10, at 8:30 am ET. To access the conference call, please dial 1-877-407-0784 (U.S.) or 1-201-689-8560 (international). Reference conference ID 13728508.

The webcast can be accessed using the following link:

https://viavid.webcasts.com/starthere.jsp?ei=1541038&tp_key=a8e9864837

or under “Events” on the “Investors” section of the company’s website, https://ir.docgo.com/. A replay of the webcast will be archived on the company’s investor relations page through June 2, 2022 at approximately 5:00 PM Eastern Time. 

About DocGo

DocGo is a leading provider of last-mile mobile care services and integrated medical transportation solutions. DocGo is disrupting the traditional four-wall healthcare system by providing care to patients where and when they need it. DocGo's innovative technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com.

Forward-Looking Statements

This announcement contains forward-looking statements (including within the meaning of Section 21E of the U.S. Securities Exchange Act of 1934, as amended, and Section 27A of the U.S. Securities Act of 1933, as amended) concerning DocGo. These statements include, but are not limited to, statements that address our expected future business and financial performance and statements about (i) our plans, objectives and intentions with respect to future operations, services and products, including our transition to non-COVID related services, geographic expansion, new and existing contracts and our “Zero Emission” initiative, (ii) our competitive position and opportunities, , including our ability to realize the benefits from our operating model, and (iii) other statements identified by words such as "may", "will", "expect", "intend", "plan", "potential", "believe", "seek", "could", "estimate", "judgment", "targeting", "should", "anticipate", "predict" "project", "aim", "goal", "outlook", "guidance", and similar words, phrases or expressions. These forward-looking statements are based on management's current expectations and beliefs, as well as assumptions made by, and information currently available to, management, and current market trends and conditions. Forward-looking statements inherently involve risks and uncertainties, many of which are beyond our control, and which may cause actual results to differ materially from those contained in our forward-looking statements. Accordingly, you should not place undue reliance on such statements. Particular uncertainties that could materially affect current or future results include possible accounting adjustments made in the process of finalizing reported financial results; any risks associated with global economic conditions and concerns; the effects of global outbreaks of pandemics or contagious diseases or fear of such outbreaks, such as the COVID-19 coronavirus pandemic; competitive pressures; pricing declines; rates of growth in our target markets; our ability to improve gross margins; cost-containment measures; legislative and regulatory actions; the impact of legal proceedings and compliance risks; the impact on our business and reputation in the event of information technology system failures, network disruptions, cyber-attacks, or losses or unauthorized access to, or release of, confidential information; and the ability of the company to comply with laws and regulations regarding data privacy and protection. We undertake no intent or obligation to publicly update or revise any of these forward-looking statements, whether as a result of new information, future events or otherwise.

Non-GAAP Financial Measures

The following information provides definition and reconciliation of the non-GAAP financial measure presented in this earnings release to the most directly comparable financial measure calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measure should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this earnings release. The non-GAAP financial measure in this earnings release may differ from similarly titled measures used by other companies.

3

 

Adjusted EBITDA

Adjusted EBITDA is considered a non-GAAP financial measure under the Securities and Exchange Commission’s (“SEC”) rules because it excludes certain amounts included in net income (loss) calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it facilitates comparison of the current period performance with that of the comparable prior period. In addition, Adjusted EBITDA affords investors a view of what management considers to be the Company’s core operating performance as well as the ability to make a more informed assessment of such operating performance as compared with that of the prior period.

The table below reflects the calculation of Adjusted EBITDA for the three months ended March 31, 2022 compared to the prior year’s first quarter ended March 31, 2021:

 

DocGo Inc. and Subsidiaries

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   March 31,   December 31, 
   2022   2021 
   Unaudited   Audited 
ASSETS        
Current assets:        
Cash and cash equivalents  $188,353,909   $175,537,221 
Accounts receivable, net of allowance of $8,023,348 and $7,377,389 as of March 31, 2022 and December 31, 2021, respectively   76,167,670    78,383,614 
Prepaid expenses and other current assets   3,649,206    2,111,656 
Total current assets   268,170,785    256,032,491 
           
Property and equipment, net   12,624,427    12,733,889 
Intangibles, net   10,579,310    10,678,049 
Goodwill   8,686,966    8,686,966 
Restricted cash   10,370,398    3,568,509 
Operating lease right-of-use assets   3,962,805    4,195,682 
Finance lease right-of-use assets   8,658,897    9,307,113 
Equity method investment   520,063    589,058 
Other assets   1,622,653    3,810,895 
Total assets  $325,196,304   $309,602,652 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
           
Current liabilities:          
Accounts payable  $15,120,928   $15,833,970 
Accrued liabilities   38,174,025    35,110,877 
Line of credit   1,025,881    25,881 
Notes payable, current   593,831    600,449 
Due to seller   1,411,169    1,571,419 
Operating lease liability, current   1,404,651    1,461,335 
Finance lease liability, current   3,262,004    3,271,990 
Total current liabilities   60,992,489    57,875,921 
           
Notes payable, non-current   1,171,306    1,302,839 
Operating lease liability, non-current   2,788,103    2,980,946 
Finance lease liability, non-current   6,402,846    6,867,420 
Warrant liabilities   13,577,251    13,518,502 
Total liabilities   84,931,995    82,545,628 
           
Commitments and Contingencies          
           
STOCKHOLDERS’ EQUITY:          
Common stock ($0.0001 par value; 500,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 100,475,958 and 100,133,953 shares issued and outstanding as of March 31, 2022 and December 31,2021, respectively)   10,208    10,013 
Additional paid-in-capital   284,938,732    283,161,216 
Accumulated deficit   (52,927,020)   (63,556,714)
Accumulated other comprehensive loss   (38,364)   (32,501)
Total stockholders’ equity attributable to DocGo Inc. and Subsidiaries   231,983,556    219,582,014 
Noncontrolling interests   8,280,753    7,475,010 
Total stockholders’ equity   240,264,309    227,057,024 
Total liabilities and stockholders’ equity  $325,196,304   $309,602,652 

4

 

 

DocGo Inc. and Subsidiaries

 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND

COMPREHENSIVE INCOME (LOSS)

 

   Three Months Ended 
   March 31, 
   2022   2021 
Revenue, net  $117,891,552   $49,688,856 
Expenses:          
Cost of revenues (exclusive of depreciation and amortization, which is shown separately below)   77,987,573    35,860,742 
Operating expenses:          
General and administrative   23,860,616    12,035,526 
Depreciation and amortization   2,201,021    1,597,676 
Legal and regulatory   1,347,983    656,658 
Technology and development   1,141,833    569,351 
Sales, advertising and marketing   1,257,961    842,861 
Total expenses   107,796,987    51,562,814 
Income (loss) from operations   10,094,565    (1,873,958)
           
Other income (expenses):          
Interest income (expense), net   (135,606)   (115,009)
Loss on remeasurement of warrant liabilities   (58,749)   - 
Loss on initial equity method investments   (83,341)   - 
Other income (loss)   (4,253)   - 
Total other income (expense)   (281,949)   (115,009)
           
Net income (loss) before income tax benefit (expense)   9,812,616    (1,988,967)
Income tax expense   (440,179)   (10,029)
Net income (loss)   9,372,437    (1,998,996)
Net loss attributable to noncontrolling interests   (1,257,257)   (320,632)
Net income (loss) attributable to stockholders of DocGo Inc. and Subsidiaries   10,629,694    (1,678,364)
Other comprehensive income (loss)          
Foreign currency translation adjustment   (5,863)   7,998 
Total comprehensive gain (loss)  $10,623,831   $(1,670,366)
           
Net income (loss) per share attributable to DocGo Inc. and Subsidiaries - Basic  $0.11   $(0.03)
Weighted-average shares outstanding - Basic   100,177,082    58,388,866 
           
Net income (loss) per share attributable to DocGo Inc. and Subsidiaries - Diluted  $0.09   $(0.03)
Weighted-average shares outstanding - Diluted   115,652,049    58,388,866 

5

 

 

DocGo Inc. and Subsidiaries

 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

  

   Three Months Ended 
   March 31, 
   2022   2021 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net income (loss)  $9,372,437   $(1,998,996)
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation of property and equipment   711,878    528,840 
Amortization of intangible assets   633,363    422,024 
Amortization of finance lease right-of-use assets   855,781    646,812 
Loss from equity method investment   68,995    - 
Bad debt expense   1,154,235    678,840 
Stock based compensation   1,422,937    391,534 
Loss on remeasurement of warrant liabilities   (58,749)   - 
Changes in operating assets and liabilities:          
Accounts receivable   1,061,709    (7,138,675)
Prepaid expenses and other current assets   (1,537,550)   (2,121,543)
Other assets   2,188,242    (113,384)
Accounts payable   (671,744)   (583,363)
Accrued liabilities   3,063,148    7,903,736 
Net cash provided by (used in) operating activities   18,264,682    (1,384,175)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Acquisition of property and equipment   (602,416)   (760,049)
Acquisition of intangibles   (534,624)   (515,246)
Acquisition of businesses   -    (759)
Net cash used in investing activities   (1,137,040)   (1,276,054)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from revolving credit line   1,000,000    - 
Repayments of notes payable   (138,151)   (282,115)
Due to seller   (160,250)   - 
Noncontrolling interest contributions   2,063,000    333,025 
Proceeds from exercise of stock options   374,344    - 
Equity costs   (19,570)   - 
Payments on obligations under finance lease   (622,575)   (601,501)
Net cash provided by (used in) financing activities   2,496,798    (550,591)
           
Effect of exchange rate changes on cash and cash equivalents   (5,863)   7,998 
           
Net increase (decrease) in cash and restricted cash   19,618,577    (3,202,822)
Cash and restricted cash at beginning of period   179,105,730    34,457,273 
Cash and restricted cash at end of period  $198,724,307   $31,254,451 

 

6

 

 

DocGo Inc. and Subsidiaries

 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(CONTINUED)

 

Supplemental disclosure of cash and non-cash transactions:

 

Cash paid for interest  $68,222   $2,365 
           
Cash paid for interest on finance lease liabilities  $153,327   $121,356 
           
Cash paid for income taxes  $440,179   $7,225 
           
Right-of-use assets obtained in exchange for lease liabilities  $722,716   $1,454,029 
           
Reconciliation of cash and restricted cash          
Cash  $188,353,909   $28,134,967 
           
Restricted Cash   10,370,398    3,119,484 
           
Total cash and restricted cash shown in statement of cash flows  $198,724,307   $31,254,451 

 

7

 

 

   Three Months Ended 
   March 31, 
   2022   2021 
Primary Geographical Markets        
United States  $115,053,431   $47,681,374 
United Kingdom   2,838,121    2,007,482 
Total revenue  $117,891,552   $49,688,856 
           
Major Segments/Service Lines          
Transportation Services  $27,812,510   $19,124,020 
Mobile Health   90,079,042    30,564,836 
Total revenue  $117,891,552   $49,688,856 

 

RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA
         
    Q1 2021    Q1 2022 
    2021    2022 
Net Income/(loss) (GAAP)  $-2.0   $9.4 
(+) Net Interest expense/ (income)  $0.1   $0.1 
(+) Income Tax  $0.0   $0.4 
(+) Depreciation & amortization  $1.6   $2.2 
(+) Remeasurement of Warrant Liabilities  $0.0   $0.1 
   $-0.3   $12.2 
           
(+) Non-cash stock compensation  $0.4   $1.4 
(+) Non-recurring expense  $0.3   $0.0 
Adjusted EBITDA  $0.4   $13.6 

 

Forecasted 2022 Revenue Growth Rate with and without Covid Testing
             
in $MM  FY 2021   FY 2022   % Change 
Total Revenues  $319     $400-$420     25%-32% 
Estimated Covid Testing Revenues  $110    $55    -50%
All non-Covid testing Revenues  $209     $345-$365     65%-75% 


Contacts

Media Contact:

Janine Warner

Crowe PR

docgo@crowepr.com

(646) 916-5314

Investor Contacts:

Steven Halper

LifeSci Advisors

shalper@lifesciadvisors.com

or

ir@docgo.com

646-876-6455

8

 EX-101.SCH 3 dcgo-20220509.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 dcgo-20220509_def.xml XBRL DEFINITION FILE EX-101.LAB 5 dcgo-20220509_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common stock, par value $0.0001 per share Warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 dcgo-20220509_pre.xml XBRL PRESENTATION FILE GRAPHIC 7 image_001.jpg GRAPHIC begin 644 image_001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# H'!PD'!@H)" D+"PH,#QD0#PX. M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_ MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T] M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P 1" H *T# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#L?''Q(@\& M7]M9FQ>ZFFC\T_O0@5&XT>QCNXQ^^MO+4$#^\K X]^U<1XO\,W?PVUVTUG0IG%H[XC+')1NIC; MU4BG8#W2N7\4_$/1O"KF"XD:XO,9^SP8+#_>/1?QYJCXC\>QV?P\AURP(%Q? M($MU;G8YSG/^[@_E7)?#GX=Q:[ =?\0[[B.=BT,+L?WO/+N>IR;QH?[K/>Z^;_T&NM\+_$S1?$TZVJL]G>M]V"? W_[K=#].M="NAZ6D A7 M3;,1 8V"!<8^F*\T^(WPTM;73Y=:\/Q&W>W_ 'DUO&?E*CJZ>A'7 IZ,-3UF MLGQ!XHTOPQ:"XU2Y$8;[D:C<\A]%7O\ RKFO 7CD:GX*N;S5)-UQI:D7#]Y% M RK?4@8^HK@_#FC7OQ3\5W6I:M*Z641!DVGH#]V)/3CJ?ZFE8+F]=?':)9B+ M317:,=YK@*3^ !_G6MH7QFT;4IEAU&"73F;@2,P>//NPZ?B*Z_3_ SHVEVX M@L],M8T'_3,$GZD\G\:Y[Q=\,M)U^TEDL;>*QU$#*21+M5SZ,HXQ[]:- U.T M219$5XV#(PRK*<@CUJ.YNX;.!I;B18T7J37EGPC\07UI?7'AG5$E41[FM]ZG M]VRGYTSZ=Q]#7073S>)M>\B-RL"$A3V51U;ZFM*=+G;N]$B1 MHW'C>%'(M[5W'9G;;G\*6V\;6\CA;FW>('^)6W 5KV6C6-C&%BMT)[NXRQ_& MFZAH5CJ$9#PJCXXD08(_QK3GH;*]1EGNH]+ML\XW@?Q$ M]!2^KOGY4]-[^12S!*@ZDE[R=K>9;O?&-I;N4MXVN"/X@=J_GWJM%XX4L!+9 MD+ZI)D_RK0TKPW:V,2M-&L]QCYF<9 /H!6A<:99W492:VB8'_9 (_&FY4%IR MW\R53QTUS.:3[6"PU.VU*'S+:0,!U4\%?J*MUPM_:S>%]5BN+9F:%ONY[CNI MKMK>9;BWCFC.4D4,/QJ*M-1M*+NF;X7$RJ-TZBM*._\ F>5_%7Q3K>B>)K*U MTF_EMXY;8,40*=S%R.X^E9$__"T?(D\_[9Y.T[]_D[=N. M +=,G_MJ:]+\1?V+XCT2YTVXU>WB2=<;X[E00>H[\CV[UGL=1\^^'CJH\06O M]@[_ .T=_P"Z\O\ 7/;;Z]L5[/\ %'=_PK.3^T?*^U;H<^7G;YFX9VYYQUIG MA73_ Q\/]*>:YU>PEO)!^^N?,4DC^ZJ@DX]N]<3XO\ $UW\2=>M=&T*&0VB M/F/<,&1NAD;T4#-/=@8VL^=_PK'P[NSY?VJZV_F,?^S5[QX6\K_A%-)^SX\K M[)%MQ_NBN>\1^ H[OX=PZ)88-Q8H'MV/&]QG.?\ >R?SKDOAQ\1(M"@.@^(M M]O' Y6&9P?W7/*..HP>AI;H%H>R56U#R_P"SKGSL>5Y3[\],8.:B77-+> 3+ MJ-F8B,[Q.N,?7->9_$;XEVMUI\NB^'Y3BX_2IO 7@8:9X*NK/ M5(]MQJBDW"=XU(PJ_4 Y^IK@_#FLWOPL\5W6FZM$[V4I DVCJ!]V5/7CJ/ZB MF]2=CWBBLO3_ !-HVJ6RSV>IVLB'_IH 1]0>1^-<[XN^)NDZ!:2QV-Q%?:B1 MA(HFW*A]6(XP/3K4E'87/_'M+M^]L./KBN5\$;?/N\_?V+CZ9.:Y;X1^'[Z[ MOKCQ-JCRL)-RV^]C^\9C\[X].P_&N@NHYO#&O>?&A:!R2OHRGJOU%=-%G2PW4>IVV>,;R/X2.AK?W%/D6C:_$\_\ ?3H^VDW)1DFO1=3K12UB MZ3XDM;^)5FD6&XQ\RL< ^X-7[C4[.UCWS7,2C_>R?RKB=.479H]R&(ISASQD MK&1XSV_V5%G&[SAC\CFKWAO/_"/VF[^Z?RR:YF_NYO%&JQP6RE85^[GL.[&N MUMX5M[:.&,82-0H^@K:JN2E&#WW.+"R]MBIUH_#:WJ]I M+#&8B!&'#+G([C!Y-E8EM_@3:I(#/K,S M)W$<"J3^))KO?#OA/2?"UNT6EVP1G_UDSG=(_P!6_ITHHHNQV-JN6\4_#S1O M%3F>XC:WO,8^T08#'_>'1OQHHI <6?@0/.^77!Y6>]K\W_H6*ZWPO\,]%\,S M+=*KWEZOW9Y\?)_NKT'UZT44[L5CL*R/$'A?2_$]F+?5+82!?N2*=KQGU5NU M%%(9YY=_ F)YBUIK3JGI-;AB/Q!%:NA?!G1M-G2;49Y=19>1&RA(\^ZCK^)H MHIW8K'H:(L:*D:A44850, #T%175I#>PM%<1K)&>H-%%).P-*2LSGKCP1"SD MV]TZ+V5UW8_&G6O@JWC<-*VA M6*%%2-1@*HX%/90ZE6 *D8((X-%%8'8DDK(Y^]\'6EPY:VD:W)ZJ!N7\JK1> M!U#@RWA*^B1X/\Z**V6(JI6N< XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover
May 09, 2022
Document Type 8-K
Amendment Flag false
Document Period End Date May 09, 2022
Entity File Number 001-39618
Entity Registrant Name DOCGO INC.
Entity Central Index Key 0001822359
Entity Tax Identification Number 85-2515483
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 35 West 35th Street
Entity Address, Address Line Two Floor 6
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10001
City Area Code (844)
Local Phone Number 443-6246
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common stock, par value $0.0001 per share  
Title of 12(b) Security Common stock, par value $0.0001 per share
Trading Symbol DCGO
Security Exchange Name NASDAQ
Warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share  
Title of 12(b) Security Warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share
Trading Symbol DCGOW
Security Exchange Name NASDAQ
XML 9 ea159635-8k_docgo_htm.xml IDEA: XBRL DOCUMENT 0001822359 2022-05-09 2022-05-09 0001822359 DCGO:CommonStockParValue0.0001PerShareMember 2022-05-09 2022-05-09 0001822359 DCGO:WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember 2022-05-09 2022-05-09 iso4217:USD shares iso4217:USD shares 0001822359 false 8-K 2022-05-09 DOCGO INC. DE 001-39618 85-2515483 35 West 35th Street Floor 6 New York NY 10001 (844) 443-6246 false false false false Common stock, par value $0.0001 per share DCGO NASDAQ Warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share DCGOW NASDAQ true false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 3 24 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://docgo.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea159635-8k_docgo.htm dcgo-20220509.xsd dcgo-20220509_def.xml dcgo-20220509_lab.xml dcgo-20220509_pre.xml ea159635ex99-1_docgo.htm http://xbrl.sec.gov/dei/2022 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ea159635-8k_docgo.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 3, "dts": { "definitionLink": { "local": [ "dcgo-20220509_def.xml" ] }, "inline": { "local": [ "ea159635-8k_docgo.htm" ] }, "labelLink": { "local": [ "dcgo-20220509_lab.xml" ] }, "presentationLink": { "local": [ "dcgo-20220509_pre.xml" ] }, "schema": { "local": [ "dcgo-20220509.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 65, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 2, "memberStandard": 0, "nsprefix": "DCGO", "nsuri": "http://docgo.com/20220509", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea159635-8k_docgo.htm", "contextRef": "From2022-05-09to2022-05-09", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://docgo.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea159635-8k_docgo.htm", "contextRef": "From2022-05-09to2022-05-09", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "DCGO_CommonStockParValue0.0001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock, par value $0.0001 per share" } } }, "localname": "CommonStockParValue0.0001PerShareMember", "nsuri": "http://docgo.com/20220509", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "domainItemType" }, "DCGO_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share" } } }, "localname": "WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember", "nsuri": "http://docgo.com/20220509", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://docgo.com/role/Cover" ], "xbrltype": "stringItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 16 0001213900-22-024978-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-22-024978-xbrl.zip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end